# Mounjaro May Lead to Greater Lean Body Mass Loss than Ozempic
Mounjaro appears to cause more loss of lean muscle tissue than Ozempic, a finding that matters for people using these medications for weight loss. Both drugs belong to the GLP-1 receptor agonist class, but they work slightly differently, and that difference may affect how your body sheds weight.
Ozempic contains semaglutide, while Mounjaro contains tirzepatide, which targets an additional hormone receptor. This dual action in Mounjaro makes it more effective at reducing appetite and blood sugar, but emerging research suggests it also strips away more muscle alongside fat.
The distinction between losing fat versus lean muscle matters significantly. Lean body mass includes muscle, bone, organs, and water. When you lose excessive muscle during weight loss, your metabolism slows, making it harder to maintain weight loss long-term. You also become weaker and more prone to falls and injury, concerns that intensify with age.
Studies comparing these medications show Mounjaro produces greater overall weight loss than Ozempic, but users also lose a higher percentage of lean tissue alongside that fat loss. Someone losing 20 pounds on Mounjaro might lose more muscle than someone losing 15 pounds on Ozempic.
This doesn't mean Mounjaro is worse. For people with type 2 diabetes, the medication's superior blood sugar control outweighs the lean mass concern. For weight loss alone, the trade-off requires careful consideration.
Resistance training offers a practical solution. People using either medication who prioritize strength work lose less muscle mass overall. Building muscle while taking these drugs becomes even more important than during typical dieting.
Talk with your doctor about which medication fits your specific situation. If you choose Mounjaro, adding weight training to your routine